Bionano Genomics (NASDAQ:BNGO) just reported results for the first quarter of 2024.
- Bionano Genomics reported earnings per share of -60 cents. This was above the analyst estimate for EPS of -64 cents.
- The company reported revenue of $8.77 million.
- This was 3.29% better than the analyst estimate for revenue of $8.49 million.